The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Current challenges in biomarker testing in Latin America
Luis Raez, MD, Memorial Cancer Institute, Pembroke Pines, FL, discusses the need for more liquid biopsies in Latin America. Due to various issues such as cost, tissue biopsies are more prevalent in this region of the world, despite certain mutations such as EGFR being more common in this population. Detection of these mutations will need the adoption of techniques such as next generation sequencing (NGS). This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
